Detalhe da pesquisa
1.
Identifying Effective Durations of Antibiotic Therapy for the Treatment of Carbapenem-resistant Enterobacterales Bloodstream Infections: A Multicenter Observational Study.
Clin Infect Dis
; 78(1): 27-30, 2024 01 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-37584360
2.
Successful Treatment of Carbapenem-Resistant Acinetobacter baumannii Meningitis with Sulbactam-Durlobactam.
Clin Infect Dis
; 2024 Apr 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-38630890
3.
The metallo-ß-lactamases strike back: emergence of taniborbactam escape variants.
Antimicrob Agents Chemother
; 68(2): e0151023, 2024 Feb 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-38174925
4.
Assessing the impact of meropenem exposure on ceftolozane/tazobactam-resistance development in Pseudomonas aeruginosa using in vitro serial passage.
J Antimicrob Chemother
; 79(5): 1176-1181, 2024 May 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-38562061
5.
Cefepime versus carbapenems for treatment of AmpC beta-lactamase-producing Enterobacterales bloodstream infections.
Eur J Clin Microbiol Infect Dis
; 43(2): 213-221, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-37993680
6.
Navigating Available Treatment Options for Carbapenem-Resistant Acinetobacter baumannii-calcoaceticus Complex Infections.
Clin Infect Dis
; 76(Suppl 2): S179-S193, 2023 05 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37125467
7.
Adherence to Antimicrobial Prophylaxis Guidelines for Elective Surgeries Across 825 US Hospitals, 2019-2020.
Clin Infect Dis
; 76(12): 2106-2115, 2023 06 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-36774539
8.
Breaking Down the Breakpoints: Rationale for the 2022 Clinical and Laboratory Standards Institute Revised Piperacillin-Tazobactam Breakpoints Against Enterobacterales.
Clin Infect Dis
; 77(11): 1585-1590, 2023 11 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-36001445
9.
Infectious Diseases Society of America 2023 Guidance on the Treatment of Antimicrobial Resistant Gram-Negative Infections.
Clin Infect Dis
; 2023 Jul 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-37463564
10.
Patterns, Predictors, and Intercenter Variability in Empiric Gram-Negative Antibiotic Use Across 928 United States Hospitals.
Clin Infect Dis
; 76(3): e1224-e1235, 2023 02 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35737945
11.
Is Carbapenem Therapy Necessary for the Treatment of Non-CTX-M ESBL-Producing Enterobacterales Bloodstream Infections?
Clin Infect Dis
; 2023 Nov 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-37972276
12.
Defining the Optimal Duration of Therapy for Hospitalized Patients With Complicated Urinary Tract Infections and Associated Bacteremia.
Clin Infect Dis
; 76(9): 1604-1612, 2023 05 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36633559
13.
Infectious Diseases Consultation Associated With Reduced Mortality in Gram-Negative Bacteremia.
Clin Infect Dis
; 77(9): 1234-1237, 2023 11 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37402637
14.
Antibiotic Indications and Appropriateness in the Pediatric Intensive Care Unit: A 10-Center Point Prevalence Study.
Clin Infect Dis
; 76(3): e1021-e1030, 2023 02 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-36048543
15.
Priorities and Progress in Gram-negative Bacterial Infection Research by the Antibacterial Resistance Leadership Group.
Clin Infect Dis
; 77(Suppl 4): S305-S313, 2023 10 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-37843118
16.
Antimicrobial Agents and Chemotherapy Launches a New Section Focused on Innovative Antimicrobial Stewardship Studies.
Antimicrob Agents Chemother
; 67(6): e0052623, 2023 06 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-37184258
17.
Validation and Application of Long-Read Whole-Genome Sequencing for Antimicrobial Resistance Gene Detection and Antimicrobial Susceptibility Testing.
Antimicrob Agents Chemother
; 67(1): e0107222, 2023 01 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-36533931
18.
Interlaboratory comparison of Pseudomonas aeruginosa phage susceptibility testing.
J Clin Microbiol
; 61(12): e0061423, 2023 12 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-37962552
19.
Administration of a ß-Lactam Prior to Vancomycin as the First Dose of Antibiotic Therapy Improves Survival in Patients With Bloodstream Infections.
Clin Infect Dis
; 75(1): 98-104, 2022 08 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-34606585
20.
Progressive Development of Cefiderocol Resistance in Escherichia coli During Therapy is Associated With an Increase in blaNDM-5 Copy Number and Gene Expression.
Clin Infect Dis
; 75(1): 47-54, 2022 08 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-34618008